Skip to main content

Table 1 Sialic acid levels in BAL and sera samples of patients with malignant lung diseases (mg/dl).

From: Comparison of serum and bronchoalveolar lavage fluid sialic acid levels between malignant and benign lung diseases

Patient No.

Age

BAL Fluid

Serum

Diagnosis

Tumor Localization

Tumor Stage

1

55

3.75

64.25

Epidermoid carcinoma

Central

Stage IIB

2

50

1.87

88.60

Epidermoid carcinoma

Central

Stage IIIA

3

64

5.97

73.69

Epidermoid carcinoma

Central

Stage IIIA

4

68

11.09

143.96

Epidermoid carcinoma

Peripheral

Stage IIIB

5

60

7.39

83.93

Small cell carcinoma

Central

Stage IV

6

55

7.52

101.74

Epidermoid carcinoma

Central

Stage IIB

7

72

7.78

134.70

Small cell carcinoma

Central

Stage IV

8

59

8.8

46.07

Adenocarcinoma

Peripheral

Stage IIIB

9

61

10.4

73.82

Epidermoid carcinoma

Central

Stage IB

10

45

2.64

86.26

Adenocarcinoma

Peripheral

Stage IIB

11

59

11.6

103.24

Epidermoid carcinoma

Central

Stage IIIA

12

66

4.4

92.14

Epidermoid carcinoma

Peripheral

Stage IIB

13

62

20

66.61

Epidermoid carcinoma

Central

Stage IB

14

48

16.4

103.24

Epidermoid carcinoma

Central

Stage IIIA

15

51

9.2

82.71

Small cell carcinoma

Central

Stage IV

16

50

11.6

27

Epidermoid carcinoma

Central

Stage IIIA

17

70

4.4

87.98

Epidermoid carcinoma

Peripheral

Stage IIB

18

48

17.9

91.86

Adenocarcinoma

Peripheral

Stage IIIA

19

75

9.2

65.77

Epidermoid carcinoma

Central

Stage IIIB

20

65

28.8

42.35

Large cell carcinoma

Central

Stage IIIA

21

68

15.9

61.61

Large cell Carcinoma

Central

Stage IIIB